The clinical characteristic and outcome of skin and soft tissue infection in immunosuppressive patients with nephrotic syndrome.
Adolescent
Adult
Aged
Anti-Bacterial Agents
/ therapeutic use
C-Reactive Protein
/ metabolism
CD4 Lymphocyte Count
CD8-Positive T-Lymphocytes
Cellulitis
/ blood
Child
Cyclophosphamide
/ adverse effects
Female
Humans
Immunosuppression Therapy
/ adverse effects
Immunosuppressive Agents
/ adverse effects
Leg
Male
Middle Aged
Nephrotic Syndrome
/ drug therapy
Prednisone
/ adverse effects
Procalcitonin
/ blood
Retrospective Studies
Serum Albumin
/ metabolism
Severity of Illness Index
Soft Tissue Infections
/ blood
Tacrolimus
/ adverse effects
Young Adult
Immunosuppressive therapy
Infection
Mortality
Nephrotic syndrome
Journal
Clinical and experimental nephrology
ISSN: 1437-7799
Titre abrégé: Clin Exp Nephrol
Pays: Japan
ID NLM: 9709923
Informations de publication
Date de publication:
Sep 2020
Sep 2020
Historique:
received:
04
11
2019
accepted:
16
04
2020
pubmed:
29
4
2020
medline:
13
7
2021
entrez:
29
4
2020
Statut:
ppublish
Résumé
Skin and soft tissue infection (SSTI) is the most common of infectious diseases with high morbidity and mortality. However, the clinical characteristics of SSTI in patients with nephrotic syndrome (NS), especially in those patients who received immunosuppressive therapy, are still lacking. The present study was conducted to investigate the clinical characteristics and outcomes of SSTI in patients with NS. A retrospective study was carried out among the patients diagnosed with NS and SSTI, who have priorly received or currently have been receiving immunosuppressive therapy between April 2011 and January 2019; the clinical profile included patient's baseline characteristics, clinical presentation, microbiological findings, treatment, and prognosis. A total of 70 patients were analyzed. Results showed that more than half of the patients were under 35 years old, and moderate infection was the most common type of SSTI. Leg and cellulitis were the most common site of lesion and the typical clinical manifestation of SSTI, respectively. Patients in the severe infection group have a higher level of procalcitonin (PCT) and C-reactive protein (CRP), while a lower level of albumin, CD4 Patients with NS and SSTI usually showed a satisfying outcome with proper anti-infection treatment, but severe SSTI can be life-threatening.
Identifiants
pubmed: 32342290
doi: 10.1007/s10157-020-01893-w
pii: 10.1007/s10157-020-01893-w
doi:
Substances chimiques
Anti-Bacterial Agents
0
Immunosuppressive Agents
0
Procalcitonin
0
Serum Albumin
0
Cyclophosphamide
8N3DW7272P
C-Reactive Protein
9007-41-4
Prednisone
VB0R961HZT
Tacrolimus
WM0HAQ4WNM
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
779-788Subventions
Organisme : the National Natural Science Foundation of China
ID : 81800616
Organisme : Chongqing science and health joint medical research project
ID : 2018NXM040